Gene therapy makes a big comeback

After running into a buzzsaw of controversy over the safety of gene therapy studies, the Los Angeles Times notes that the field has made a big comeback. There are currently more than 300 gene therapy trials underway and solid evidence that the approach can help patients with Parkinson's and other lethal immune disorders. Gene therapy works by replacing the faulty genes that cause the disorders with healthy ones.

- read the The Los Angeles Times report on gene therapy

Suggested Articles

J&J's EGFR-fighting combo stopped tumor growth in 60% of patients whose lung cancer got worse after taking AstraZeneca's Tagrisso.

Amgen's KRAS inhibitor curbed tumor growth in 88% of patients with non-small cell lung cancer, shrinking tumors in one-third of them.

The trial squeezed under the bar for statistical significance by improving on the median progression-free survival of Zytiga by two months.